Alnylam Pharmaceuticals, Inc. (ALNY)

NetscribeBiotech (86.66) Submitted: 2/14/07 8:04 AM : Start Price: $21.06 ALNY Score: -48.26

Alnylam Pharmaceuticals, Inc. (Alnylam) is a biopharmaceutical company, which seeks to develop and commercialize new drugs that work through a discovered system in cells known as RNA interference (RNAi). Using RNAi the company intendeds to produce dr...

Report this Post Replies: 0 | Reply | Permalink

djhostile (< 20) Submitted: 1/19/07 3:02 PM : Start Price: $21.46 ALNY Score: 45.41

Alnylam has better IP than any other company involved with RNAi. Considering that Merck purchased Sirna for double their market value, and Sirna's IP pales in comparison than Alnylam's, I expect Alnylam to do extremely well in both the near and long ...

Report this Post Replies: 1 | Reply | Permalink

daveosome (74.77) Submitted: 11/14/06 11:32 AM : Start Price: $19.49 ALNY Score: 54.43

It's overvalued right now around 20 because of the RNAI buyout. The price will swing dramatically over the next few years as this biotech doesn't yet have a product. Long term, it could be a moon shot because the technology could transform the drug...

Report this Post Replies: 0 | Reply | Permalink

Fuma102 (83.25) Submitted: 12/09/06 12:29 AM : Start Price: $23.94 ALNY Score: -33.58

ok people, lets start from the top - RNAi drugs are NOT going to happen within the next 6 years. let me repeat - NOT GOING TO HAPPEN. too many biological unknowns, too much background "noise" for this to be an effective treatment. ALNY is not prof...

Report this Post Replies: 4 | Reply | Permalink

daviddai (49.81) Submitted: 3/08/07 3:06 PM : Start Price: $17.96 ALNY Score: -65.38

The company is trading at 18/share. This price is overvalued for a 600M Market Cap company. 1. weak product pipeline. With the exception of 1 product, all other proudcts are at preclinical stage, which means that it'll take at least 3 years for th...

Report this Post Replies: 0 | Reply | Permalink

lanoush (< 20) Submitted: 1/07/07 3:52 PM : Start Price: $20.60 ALNY Score: -48.96

Another antisense play that saw rapid appreciation after Sirna was acquired.

Report this Post Replies: 0 | Reply | Permalink

nepedal (53.07) Submitted: 5/11/08 6:11 PM : Start Price: $28.12 ALNY Score: 18.24

amazing science. we'll see if they can get it to work, though

Report this Post Replies: 0 | Reply | Permalink

biotek2893319b (82.52) Submitted: 11/01/06 4:01 PM : Start Price: $16.79 ALNY Score: 73.04

After the bought of Sirna (RNAI) by Merck, I am quite convinced the valuation of ALNY will go to the low 30s within the next few months. RNAI is a rulebreaker technology, I am still laughing of Charly Travers´s calls on these two companies! Come on C...

Report this Post Replies: 0 | Reply | Permalink

stratton6 (99.60) Submitted: 7/20/06 12:32 AM : Start Price: $12.93 ALNY Score: -108.19

There are lots of obsticles still to overcome before siRNA will be a drug candidate. THere is still too much unknown for delivery and side effects. While this company may make some headway it is unlikely that it will bring an actual siRNA to market...

Report this Post Replies: 1 | Reply | Permalink

nrkrishna (22.87) Submitted: 8/27/08 1:35 PM : Start Price: $28.87 ALNY Score: 10.82

nice pullback - speculative pick

Report this Post Replies: 0 | Reply | Permalink